Trial shows virus treatment effective against skin cancer

It was the first time an advanced-stage trial of this type of drug has shown such positive results, according to scientists from The Institute of Cancer Research in London who published their study on Tuesday in the American Journal of Clinical Oncology.

The dramatic results, showing a large jump in survival length, could lead the drug T-VEC (Talimogene Laherparepvec) to be approved by US and European drug regulators.

Researchers randomly selected 436 patients with inoperable advanced melanoma to receive an injection of T-VEC made by US company Amgen.

In the study, more than 16% of those treated with the drug had a treatment response lasting longer than six months, compared with 2% in the control groups.

Some patients have been in remission for more than three years, the study said. Results were more pronounced in patients with less advanced skin cancer and in those who had no prior treatment, indicating T-VEC could be a first-line treatment.


Among 163 patients with less advanced melanoma, people treated with T-VEC survived an average of 41 months compared to 21.5 months for 66 patients treated with other therapy.

“There is increasing excitement over the use of viral treatments like T-VEC for cancer, because they can launch a two-pronged attack on tumours – both killing cancer cells directly and marshalling the immune system against them,” said Kevin Harrington from The Institute of Cancer Research.

The drug uses a version of the herpes virus with two key genes removed to prevent it from affecting healthy cells, the scientists said. – AFP

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Related stories

Testing sewage: The Covid canary in our wastewater

Local scientists are using wastewater-based epidemiology to trace the SARS-CoV-2 virus in South Africa’s sewage system, which could act as an early warning system for outbreaks of Covid-19, as well as other diseases

Argentina ex-president Macri accused of spying on 400 journalists

The complaint states that the background checks on journalists were "neither ordered nor authorised by any magistrate"

Manchester City owners score silver

Club’s parent company awarded global record valuation after United States investment

Only 1.4% of cars made are electric

In the face of the climate emergency, it is critical for investors to show companies the path to follow

It’s Tesla vs Ford in truck Twar

'Better than a Ford F-150, faster than a Porsche 911'

Boks speedo up against cancer

Faf de Klerk captained the challenge to team mates and other men to get themselves screened
Advertising

Subscribers only

SAA bailout raises more questions

As the government continues to grapple with the troubles facing the airline, it would do well to keep on eye on the impending Denel implosion

ANC’s rogue deployees revealed

Despite 6 300 ANC cadres working in government, the party’s integrity committee has done little to deal with its accused members

More top stories

It’s not a ‘second wave’: Covid resurges because safety measures...

A simple model shows how complacency in South Africa will cause the number of infections to go on an upward trend again

Unisa shortlists two candidates for the vice-chancellor job

The outgoing vice-chancellor’s term has been extended to April to allow for a smooth hand-over

How US foreign policy under Donald Trump has affected Africa

Lesotho has been used as a microcosm in this article to reflect how the foreign policy has affected Africa

Trouble brewing for Kenya’s coffee growers

Kenyan farmers say theft of their crop is endemic – and they suspect collusion
Advertising

press releases

Loading latest Press Releases…

The best local and international journalism

handpicked and in your inbox every weekday